FDA panel to discuss Xenazine

FDA's Peripheral and Central Nervous System Drugs Advisory Committee will meet on Dec. 6 to discuss an NDA for Xenazine tetrabenazine from Prestwick (Washington, D.C.) to treat chorea associated with ...